Shane Aaron Johnson's most recent trade in InMed Pharmaceuticals Inc was a trade of 1,500 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc | Johnson Aaron Shane | Sr VP & General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 1,500 | 3,900 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Aaron Shane Johnson | Sr VP & General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2023 | 40,000 | 48,000 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Shane Aaron Johnson | Sr VP & General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 4,200 | 8,000 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Shane Aaron Johnson | Sr. VP & General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 4,200 | 8,000 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Shane Aaron Johnson | SVP, GM of BayMedica LLC | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 06 Jan 2022 | 8,500 | 304,595 | - | 1.3 | 10,710 | Common Stock |
| InMed Pharmaceuticals Inc | Shane Aaron Johnson | SVP, GM of BayMedica LLC | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 30 Dec 2021 | 8,093 | 296,095 | - | 1.3 | 10,736 | Common Stock |
| InMed Pharmaceuticals Inc | Shane Aaron Johnson | SVP, GM of BayMedica LLC | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 15 Nov 2021 | 5,000 | 288,002 | - | 1.4 | 6,845 | Common Stock |